DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
88.43
+1.69 (1.95%)
Jul 25, 2025, 1:32 PM - Market open
DexCom Employees
DexCom had 10,300 employees as of December 31, 2024. The number of employees increased by 700 or 7.29% compared to the previous year.
Employees
10,300
Change (1Y)
700
Growth (1Y)
7.29%
Revenue / Employee
$402,718
Profits / Employee
$51,961
Market Cap
34.67B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10,300 | 700 | 7.29% |
Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
Dec 31, 2022 | 7,600 | 600 | 8.57% |
Dec 31, 2021 | 7,000 | 600 | 9.38% |
Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
Dec 31, 2018 | 3,900 | 910 | 30.43% |
Dec 31, 2017 | 2,990 | 690 | 30.00% |
Dec 31, 2016 | 2,300 | 791 | 52.42% |
Dec 31, 2015 | 1,509 | 448 | 42.22% |
Dec 31, 2014 | 1,061 | 296 | 38.69% |
Dec 31, 2013 | 765 | 67 | 9.60% |
Dec 31, 2012 | 698 | 78 | 12.58% |
Dec 31, 2011 | 620 | 100 | 19.23% |
Dec 31, 2010 | 520 | 135 | 35.06% |
Dec 31, 2009 | 385 | 81 | 26.64% |
Dec 31, 2008 | 304 | 52 | 20.63% |
Dec 31, 2007 | 252 | -8 | -3.08% |
Dec 31, 2006 | 260 | 105 | 67.74% |
Dec 31, 2005 | 155 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
DXCM News
- 2 days ago - Tenovi Expands Access to Glucose Data for Remote Patient Monitoring and Cardiometabolic Programs Through Dexcom Integration - Business Wire
- 4 days ago - DexCom: Delivering Consistent Growth - Seeking Alpha
- 4 days ago - 15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them - Market Watch
- 8 days ago - Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews - Business Wire
- 15 days ago - Johnson Fistel Continues Investigation on Behalf of DexCom, Inc. Shareholders - GlobeNewsWire
- 17 days ago - The Best Growth Stocks to Buy - Kiplinger
- 24 days ago - Dexcom Schedules Second Quarter 2025 Earnings Release and Conference Call for July 30, 2025 at 4:30 p.m. Eastern Time. - Business Wire
- 5 weeks ago - Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 - Business Wire